Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories: Dara Grantham Wright

Bio-Rad Laboratories has appointed Dara Grantham Wright as executive vice president of its clinical diagnostics group. She will replace John Hertia, who retired Dec. 31, 2019. Grantham Wright most recently served as VP and general manager of the protein and cell analysis biosciences division at Thermo Fisher Scientific. She has also held senior positions at Affymetrix, Boreal Genomics, and Becton Dickinson.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.